News Coverage 06.07.22 Share on Twitter Share on Facebook Share on LinkedIn Three-Arm First-Line Chemoimmunotherapy Study in Patients With Metastatic Pancreatic Cancer Related Announcement, Press Release Biomarkers May Predict Better Treatment Options Announcement, Press Release Parker Institute Awards $525,000 to Advance Diverse Talent in Cancer Research Announcement PICI Network Investigators Propel Immunotherapy Progress at SITC 2024
Announcement, Press Release Parker Institute Awards $525,000 to Advance Diverse Talent in Cancer Research